Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper B Andersen

Showing results (101-110 of 149) with videos related to

Pageof 15
Sort By:
Cell|August 2, 2014
p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancerDarjus F Tschaharganeh, Wen Xue, Diego F Calvisi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2020
Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract CancersDan Høgdall, Colm J O'Rourke, Christian Dehlendorff, et al.
Science Advances|January 17, 2025
Pellino 3 E3 ligase promotes starvation-induced autophagy to prevent hepatic steatosisSrinivasa P Kolapalli, Carsten J Beese, Steven E Reid, et al.
Hepatology (Baltimore, Md.)|November 1, 2021
Mucosal-associated invariant T-cell tumor infiltration predicts long-term survival in cholangiocarcinomaChristine L Zimmer, Iva Filipovic, Martin Cornillet, et al.
Hepatology (Baltimore, Md.)|June 19, 2012
Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinomaNaoki Oishi, Mia R Kumar, Stephanie Roessler, et al.
Theranostics|January 6, 2022
Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilitiesXiang-Yu Wang, Wen-Wei Zhu, Zheng Wang, et al.
BMC Cancer|October 7, 2021
Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinomaMarcell Tóth, Lilija Wehling, Lena Thiess, et al.
Hepatology (Baltimore, Md.)|May 7, 2021
Extracellular Signal-Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma CellsAlessandra Gentilini, Giulia Lori, Alessandra Caligiuri, et al.
JCI Insight|August 10, 2021
Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesisCarolin Czauderna, Alicia Poplawski, Colm J O'Rourke, et al.
Hepatology (Baltimore, Md.)|April 12, 2019
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene TherapyElisa Lozano, Rocio I R Macias, Maria J Monte, et al.
Pageof 15

Showing results (101-110 of 149) with videos related to

Sort By:
Pageof 15
Cell|August 2, 2014
p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancerDarjus F Tschaharganeh, Wen Xue, Diego F Calvisi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2020
Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract CancersDan Høgdall, Colm J O'Rourke, Christian Dehlendorff, et al.
Science Advances|January 17, 2025
Pellino 3 E3 ligase promotes starvation-induced autophagy to prevent hepatic steatosisSrinivasa P Kolapalli, Carsten J Beese, Steven E Reid, et al.
Hepatology (Baltimore, Md.)|November 1, 2021
Mucosal-associated invariant T-cell tumor infiltration predicts long-term survival in cholangiocarcinomaChristine L Zimmer, Iva Filipovic, Martin Cornillet, et al.
Hepatology (Baltimore, Md.)|June 19, 2012
Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinomaNaoki Oishi, Mia R Kumar, Stephanie Roessler, et al.
Theranostics|January 6, 2022
Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilitiesXiang-Yu Wang, Wen-Wei Zhu, Zheng Wang, et al.
BMC Cancer|October 7, 2021
Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinomaMarcell Tóth, Lilija Wehling, Lena Thiess, et al.
Hepatology (Baltimore, Md.)|May 7, 2021
Extracellular Signal-Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma CellsAlessandra Gentilini, Giulia Lori, Alessandra Caligiuri, et al.
JCI Insight|August 10, 2021
Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesisCarolin Czauderna, Alicia Poplawski, Colm J O'Rourke, et al.
Hepatology (Baltimore, Md.)|April 12, 2019
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene TherapyElisa Lozano, Rocio I R Macias, Maria J Monte, et al.
Pageof 15